Image may be NSFW.
Clik here to view.
Clik here to view.
Bionomics set to begin Phase II clinical trial following initial success of...
The Sydney Morning Herald has reported that biotechnology company Bionomics is set to begin a Phase II clinical trial of its anti-cancer drug, BNC105, at up to 12 cancer treatment centers across...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Bionomics begins Phase II clinical trial of mesothelioma med in Australia
Bionomics, an Australian biotechnology company, has announced the beginning of Phase II clinical trials for its vascular disrupting agent BNC105 as a treatment for mesothelioma. The company announced...
View Article
More Pages to Explore .....
